Geninus

Geninus Current Ratio

The Current Ratio of Geninus (389030.KQ) as of Oct 16, 2026 is 49.75. In the previous year, Current Ratio was 9.11 — a change of 445.92% (higher).

Current Ratio

49.75

YoY

445.92%

Last updated:

Current Ratio of Geninus is 2025 49.75 . Current Ratio of Geninus was 2024 9.11 . It decreases by 445.92% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Geninus Stock analysis

What does Geninus do? Geninus Inc is a South Korean company based in Seoul, operating in the Health Care sector within the Biotechnology industry. The company focuses on research and development of NGS-based genome analysis technology and develops genome analysis solutions. It provides single cell analysis services, genetic testing for disease prediction, cancer genome analysis based on tissue biopsy, and personal genetic testing. Geninus Inc has 94 employees and completed its IPO on November 8, 2021. Its website is http://www.kr-geninus.com/. Geninus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Geninus stock

Current Ratio of Geninus is 49.75 in 2025.

Current Ratio of Geninus changed from 9.11 to 49.75, representing a 445.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Geninus since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Geninus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Geninus

All Key Metrics — Geninus